Alessandra Francocci
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic
Papers
3
Total Citations
26
H-Index
2
About
Dr. Alessandra Francocci is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of robotic-assisted oncologic surgery. Her primary research focuses on comparing the efficacy and safety of robot-assisted techniques against traditional open approaches for major urologic cancers, including radical cystectomy, partial nephrectomy, and radical prostatectomy. Dr. Francocci’s most impactful contribution is her 2024 propensity score-matched analysis assessing “trifecta” and “pentafecta” success rates between robot-assisted and open radical cystectomy. This study, which has already garnered 22 citations, provides critical, evidence-based benchmarks for surgical and oncological outcomes, helping to guide clinical decision-making for bladder cancer patients. She has also advanced the field by evaluating the novel Hugo™ RAS system for extraperitoneal radical prostatectomy, reporting initial outcomes from a high-volume robotic center. Her work on robot-assisted partial nephrectomy further demonstrates her commitment to refining minimally invasive techniques while ensuring midterm oncologic safety. Through these high-impact studies, Dr. Francocci is not only validating new technologies but also establishing the rigorous outcome standards necessary for the future of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3